PAMU
TCRT icon

Pictet Asset Management (UK)’s Alaunos Therapeutics TCRT Stock Holding History

Pictet Asset Management (UK)’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$56K Hold
142
– – ﹤0.01% 1734
2021
Q1 		$77K Hold
142
– – ﹤0.01% 1759
2020
Q4 		$54K Hold
142
– – ﹤0.01% 1728
2020
Q3 		$54K Buy
142
+61
+75% +$26.9K ﹤0.01% 1539
2020
Q2 		$40K Hold
81
– – ﹤0.01% 1131
2020
Q1 		$30K Buy
+81
New +$41.9K ﹤0.01% 1101

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Pictet Asset Management (UK)'s TCRT Position: Q2 2021 in Review

Pictet Asset Management (UK) held its Alaunos Therapeutics (TCRT) position steady in Q2 2021 at 142 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

Pictet Asset Management (UK) first reported a position in TCRT in Q1 2020 and has held it in 6 quarters since. The position peaked at $77K in Q1 2021. 155 funds tracked by Wall St. Rank hold TCRT as of Q2 2021.

  • Pictet Asset Management (UK) held 142 shares of Alaunos Therapeutics worth $56K as of Q2 2021.
  • Pictet Asset Management (UK) left its Alaunos Therapeutics share count unchanged in Q2 2021.
  • Alaunos Therapeutics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1734 holding.
  • Pictet Asset Management (UK) first reported a position in Alaunos Therapeutics in Q1 2020 and has held it in 6 quarters since.
  • Pictet Asset Management (UK)'s Alaunos Therapeutics position peaked at $77K in Q1 2021.
  • 155 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.